guidance.fyi
Company, ticker, metric, guidance, or anything said
INDOBORAX
1 call

Concalls & earnings callsIndo Borax & Chemicals Limited

Every summarised call, newest first. Latest is Q1 FY27, held 8 Sept 2026.

Latest quarter

Q1 FY27 snapshot

Open full brief →

Q1 FY27 delivered 31.34% revenue growth and 59.31% profit growth from better utilization and realizations while Indo Borax moved to acquire 64.26% of Kronox Lab Sciences.

MetricThis quarterChangeFive-quarter trend
Operating revenue₹70.36 Cr+31.34% increase against ₹53.57 Cr in Q1 FY 26
EBITDA₹19.8 Crup by 62.16% vs ₹12.21 Cr in Q1 FY 26
EBITDA margin28.1%—
Net profit₹16.25 Cr+59.31% increase vs ₹10.2 Cr in Q1 FY 26
Latest guidance
  • FY27 revenue Rs. 250 crores to Rs. 260 crores versus Rs. 215 crores last year with about 20% EBITDA margin
  • Q2 expected to be softer due to monsoon seasonality and higher raw material costs with Q3 picking up
  • DOT sales target of 1,500 tons in FY27 versus about 900 tons last year
  • Rs. 50 crores capex over next two to three years: about Rs. 20 crores for Boron oxide and Rs. 20 crores to Rs. 25 crores for Boric acid
  • Kronox Dahej capex of about Rs. 110 crores to be executed in phases over 18-24 months with benefits from Financial Year '29 and full impact in Financial Year '30 and '31

Said on the Q1 FY27 call.

Filed results

Reported quarterly history

From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.

QuarterRevenueNet profit (PAT)Basic EPS
Q3 FY25₹37.51 Cr-14.9% YoY-1% QoQ₹9.07 Cr+10.2% YoY-1.2% QoQ₹2.83+10.5% YoY-1% QoQ
Q2 FY25₹37.87 Cr-19.1% YoY-23.9% QoQ₹9.18 Cr+2.8% YoY-34.5% QoQ₹2.86+2.9% YoY-34.6% QoQ
Q1 FY25₹49.76 Cr-9.5% YoY+9.5% QoQ₹14.01 Cr+35% YoY+22.5% QoQ₹4.37+35.3% YoY+22.4% QoQ
Q4 FY24₹45.46 Cr-18.7% YoY+3.2% QoQ₹11.44 Cr-9.6% YoY+39% QoQ₹3.57-9.4% YoY+39.5% QoQ
Q3 FY24₹44.06 Cr-20.4% YoY-5.9% QoQ₹8.23 Cr-39.9% YoY-7.8% QoQ₹2.56-40% YoY-7.9% QoQ
Call history
  • Q1 FY27Positive tone

    Q1 FY27 delivered 31.34% revenue growth and 59.31% profit growth from better utilization and realizations while Indo Borax moved to acquire 64.26% of Kronox Lab Sciences.

    Operating revenue
    ₹70.36 Cr+31.34% increase against ₹53.57 Cr in Q1 FY 26
    EBITDA
    ₹19.8 Crup by 62.16% vs ₹12.21 Cr in Q1 FY 26
    ChemicalsVerified brief5 guidance items